Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. Am J Physiol Endocrinol Metab 305: E485-E495, 2013. First published May 20, 2013 doi:10.1152/ajpendo.00505.2012.-Obesity-related inflammation has been implicated in the pathogenesis of insulin resistance and type 2 diabetes. In this study, we addressed the potential role of interferon regulatory factor 7 (IRF7), a master regulator of type I interferon-dependent immune responses, in the regulation of energy metabolism. The expression levels of IRF7 were increased in white adipose tissue, liver tissue, and gastrocnemius muscle of both dietinduced obese mice and ob/ob mice compared with their lean counterparts. After feeding a high-fat diet (HFD) for 24 wk, IRF7 knockout (KO) mice showed less weight gain and adiposity than wild-type controls. KO of IRF7 improved glucose and lipid homeostasis and insulin sensitivity. Additionally, KO of IRF7 ameliorated diet-induced hepatic steatosis. Next, we assessed the inflammatory state of the IRF7 KO mice on the HFD. These mice showed less macrophage infiltration into multiple organs and were protected from local and systemic inflammation. This study demonstrates a role for IRF7 in diet-induced alterations in energy metabolism and insulin sensitivity. Our results also suggest that IRF7 is involved in the etiology of metabolic abnormalities, which suggests a new strategy for treating obesity and type 2 diabetes. type 2 diabetes; adiposity; fatty liver; inflammation UNDER NORMAL PHYSIOLOGICAL conditions, organisms have a finetuned regulatory network to maintain metabolic homeostasis. However, energy imbalance develops with caloric excess and compromised regulatory functions that accompany aging. This imbalance leads to obesity, nonalcoholic fatty liver diseases (NAFLD), metabolic syndrome, and type 2 diabetes, which pose great challenges to public health (5, 45a). Obesity is now recognized as a chronic low-grade inflammatory state (19). Inflammatory mediators and cytokines are overexpressed in the adipose and other tissues in the obese state (45). Infiltration of immune cells and proinflammatory M1 polarization of macrophages are also associated with obesity (24). Activation of inflammatory signaling pathways, including c-Jun NH 2 -terminal kinase (JNK)/activator protein 1 (AP1) and IKK/NF-B pathways, blunts insulin activity (13). Loss of IB kinase ε (IKKε, also known as IKKi), a target gene of NF-B, has also been reported to improve the energy balance in diet-induced obese mice (7, 33). In addition to systemic inflammation, ectopic lipid accumulation and endoplasmic reticulum (ER) stress were also proposed to explain the pathogenesis of insulin resistance (12, 34). However, the underlying mechanism of obesity-related metabolic disorders is still not completely understood.Interferon (IFN) ␣ and IFN, collectively known as type I IFNs, are the major mediators of the host immune response against viral infections (14, 31). IFN regulatory factors (IRF) are a family of transcription facto...